Novel Specific Pyruvate Kinase M2 Inhibitor, Compound 3h, Induces Apoptosis and Autophagy through Suppressing Akt/mTOR Signaling Pathway in LNCaP Cells
Open Access
Abstract
Pyruvate kinase M2 (PKM2) is a key enzyme involved in the regulation of glycolysis. Although PKM2 is overexpressed in various tumor tissues, its functional role in cancer chemotherapy remains unexplored. In this study, we investigated the anticancer activity of a new PKM2 inhibitor, compound 3h, through the cell metabolism and associated signaling pathways in prostate cancer cells. To evaluate the molecular basis of specific PKM2 inhibitors, the interactions of compounds 3h and 3K with the PKM2 protein were assessed via molecular docking. We found that, compared to compound 3K, compound 3h exhibited a higher binding affinity for PKM2. Moreover, compound 3h significantly inhibited the pyruvate kinase activity and PKM2 expression. Cytotoxicity and colony formation assays revealed the potent anticancer activity of compound 3h against LNCaP cells. Compound 3h significantly increased the apoptotic and autophagic cell death in LNCaP cells. In addition, compound 3h induced AMPK activation along with the inhibition of the mTOR/p70S6K pathway. Furthermore, compound 3h significantly inhibited glycolysis and mitochondrial respiration, as determined by analyzing the extracellular acidification rate (ECAR) and oxygen consumption rate (OCR) production. Our results revealed that compound 3h caused apoptotic and autophagic cell death in LNCaP cells by inhibiting cancer cell metabolism. Therefore, blocking glycolytic pathways using specific PKM2 inhibitors can target cancer cell metabolism in PKM2-overexpressed prostate cancer cells.Keywords
Funding Information
- National Research Foundation (NRF) of Korea (NRF-2019R1A2C2002923, NRF-2022R1A4A1018930)
- China Scholarship Council (CSC) (NRF-2019R1A2C2002923, NRF-2022R1A4A1018930)
This publication has 37 references indexed in Scilit:
- ERK1/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effectNature Cell Biology, 2012
- Remarkable inhibition of mTOR signaling by the combination of rapamycin and 1,4‐phenylenebis(methylene)selenocyanate in human prostate cancer cellsInternational Journal of Cancer, 2012
- Role of Autophagy in Cancer PreventionCancer Prevention Research, 2011
- Crosstalk between apoptosis and autophagy within the Beclin 1 interactomeThe EMBO Journal, 2010
- Prostate cancer in the elderlyUrologic Oncology: Seminars and Original Investigations, 2009
- Structural Basis for Tumor Pyruvate Kinase M2 Allosteric Regulation and Catalysis,Biochemistry, 2005
- Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate CancerNew England Journal of Medicine, 2004
- ApoptosisCell, 2002
- On the Origin of Cancer CellsScience, 1956
- THE METABOLISM OF TUMORS IN THE BODYJournal of General Physiology, 1927